Details for New Drug Application (NDA): 021887
✉ Email this page to a colleague
The generic ingredient in ALLI is orlistat. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the orlistat profile page.
Summary for 021887
Tradename: | ALLI |
Applicant: | Haleon Us Holdings |
Ingredient: | orlistat |
Patents: | 0 |
Pharmacology for NDA: 021887
Mechanism of Action | Lipase Inhibitors |
Suppliers and Packaging for NDA: 021887
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALLI | orlistat | CAPSULE;ORAL | 021887 | NDA | Haleon US Holdings LLC | 0135-0461 | 0135-0461-01 | 60 CAPSULE in 1 BOTTLE (0135-0461-01) |
ALLI | orlistat | CAPSULE;ORAL | 021887 | NDA | Haleon US Holdings LLC | 0135-0461 | 0135-0461-02 | 90 CAPSULE in 1 BOTTLE (0135-0461-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 60MG | ||||
Approval Date: | Feb 7, 2007 | TE: | RLD: | Yes |
Expired US Patents for NDA 021887
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | ALLI | orlistat | CAPSULE;ORAL | 021887-001 | Feb 7, 2007 | 4,598,089 | ⤷ Subscribe |
Haleon Us Holdings | ALLI | orlistat | CAPSULE;ORAL | 021887-001 | Feb 7, 2007 | 6,004,996 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription